Clinical trials data
Verbal Learning in cardiovascular trials: 64 registered studies
Every registered cardiovascular disease study on ClinicalTrials.gov that names Verbal Learning in an outcome measure: how often it is a primary outcome, the tests named with it, how large the studies are and when they measure it.
- Registered cardiovascular disease studies name it in an outcome measure
- 64
- Name it in a primary outcome, 33%
- 21 of 64
Tests named in the same studies
- 1
Trail Making Test31 studies, 13 as a primary outcome
- 2
Digit Span Test29 studies, 11 as a primary outcome
- 3
Verbal Fluency26 studies, 8 as a primary outcome
- 4
Stroop Color-Word Test18 studies, 6 as a primary outcome
- 5
Symbol Coding14 studies, 4 as a primary outcome
- 6
Picture Naming Test10 studies, 4 as a primary outcome
- 7
Category Fluency8 studies, 5 as a primary outcome
- 8
N-Back Task5 studies, 3 as a primary outcome
- 9
Task Switching Test4 studies, 1 as a primary outcome
- 10
Matrix Reasoning3 studies, 2 as a primary outcome
A test as a primary outcomeOnly in secondary or other outcomes
Studies by start year
A test as a primary outcomeOnly in secondary or other outcomes
Show as a table
| Start year | Studies | A test as a primary outcome |
|---|---|---|
| 2000 | 0 | 0 |
| 2001 | 0 | 0 |
| 2002 | 0 | 0 |
| 2003 | 0 | 0 |
| 2004 | 0 | 0 |
| 2005 | 0 | 0 |
| 2006 | 0 | 0 |
| 2007 | 0 | 0 |
| 2008 | 2 | 1 |
| 2009 | 1 | 1 |
| 2010 | 3 | 1 |
| 2011 | 1 | 1 |
| 2012 | 1 | 0 |
| 2013 | 2 | 2 |
| 2014 | 7 | 0 |
| 2015 | 3 | 0 |
| 2016 | 3 | 2 |
| 2017 | 2 | 1 |
| 2018 | 1 | 1 |
| 2019 | 3 | 0 |
| 2020 | 4 | 3 |
| 2021 | 4 | 2 |
| 2022 | 6 | 1 |
| 2023 | 3 | 0 |
| 2024 | 6 | 1 |
| 2025 | 8 | 4 |
| 2026 | 4 | 0 |
Phases and study sizes
By phase
- Early phase 11 studies, 0 as a primary outcome
- Phase 27 studies, 2 as a primary outcome
- Phase 31 studies, 0 as a primary outcome
- Phase 44 studies, 0 as a primary outcome
- Not applicable41 studies, 14 as a primary outcome
- Observational10 studies, 5 as a primary outcome
Participants per study
- Not applicable80 median, 32 to 116
- Observational115 median, 100 to 203
Show as a table
| Phase | Studies with a size | Median | Middle half |
|---|---|---|---|
| Not applicable | 40 | 80 | 32 to 116 |
| Observational | 10 | 115 | 100 to 203 |
When cardiovascular trials measure it
Latest time point of each outcome
- Within a day3 outcomes, 1 as a primary outcome
- Up to 4 weeks6 outcomes, 3 as a primary outcome
- 1 to 3 months8 outcomes, 2 as a primary outcome
- 3 to 6 months26 outcomes, 7 as a primary outcome
- 6 to 12 months14 outcomes, 5 as a primary outcome
- 1 to 2 years5 outcomes, 1 as a primary outcome
- Over 2 years1 outcomes, 1 as a primary outcome
- No duration given1 outcomes, 1 as a primary outcome
A test as a primary outcomeOnly in secondary or other outcomes
63 of the 64 outcome measures give a duration. A single visit counts as within a day.
Status, results, interventions and countries
Status
- Recruiting14 studies, 3 as a primary outcome
- Not yet recruiting2 studies, 1 as a primary outcome
- Active, not recruiting3 studies, 0 as a primary outcome
- Completed27 studies, 13 as a primary outcome
- Stopped early7 studies, 3 as a primary outcome
- Status unknown11 studies, 1 as a primary outcome
What they test
- Behavioral15 studies, 8 as a primary outcome
- Drug18 studies, 3 as a primary outcome
- Device5 studies, 1 as a primary outcome
- Dietary supplement5 studies, 1 as a primary outcome
- Procedure11 studies, 5 as a primary outcome
- Diagnostic test2 studies, 0 as a primary outcome
- Biological1 studies, 0 as a primary outcome
- Other14 studies, 3 as a primary outcome
- None given4 studies, 2 as a primary outcome
Intervention types as registered. A study can list several; observational studies often list none.
Where their sites are
- United States28 studies, 9 as a primary outcome
- Canada13 studies, 4 as a primary outcome
- China6 studies, 1 as a primary outcome
- Brazil2 studies, 1 as a primary outcome
- Finland2 studies, 1 as a primary outcome
- Indonesia2 studies, 1 as a primary outcome
- Denmark1 studies, 1 as a primary outcome
- France1 studies, 0 as a primary outcome
- Italy1 studies, 0 as a primary outcome
- Kazakhstan1 studies, 0 as a primary outcome
- Netherlands1 studies, 0 as a primary outcome
- Russia1 studies, 0 as a primary outcome
15 countries in all. A study with sites in several counts in each; 3 list no site.
Reported results
Completed studies with results posted on ClinicalTrials.gov, a results paper the registry links to the study, or both.
Completed cardiovascular disease studies that name Verbal Learning: 16 of 27, 59%
Every completed study with a cognitive outcome: 3,626 of 7,953, 46%
| Results | Completed cardiovascular disease studies that name Verbal Learning | Every completed study |
|---|---|---|
| Results on ClinicalTrials.gov and a paper | 6, 22% | 776, 10% |
| Results on ClinicalTrials.gov only | 6, 22% | 1,139, 14% |
| A results paper only | 4, 15% | 1,711, 22% |
| Neither | 11, 41% | 4,327, 54% |
The 64 studies
64 studies match. 21 name Verbal Learning in a primary outcome. Median size 80 participants. Median time to the primary outcome: 6 months.
Loading 64 studies; the filters turn on when they arrive.
2026 is partly planned starts.
Show as a table
| Start year | Studies | As a primary outcome |
|---|---|---|
| 2000 | 0 | 0 |
| 2001 | 0 | 0 |
| 2002 | 0 | 0 |
| 2003 | 0 | 0 |
| 2004 | 0 | 0 |
| 2005 | 0 | 0 |
| 2006 | 0 | 0 |
| 2007 | 0 | 0 |
| 2008 | 2 | 1 |
| 2009 | 1 | 1 |
| 2010 | 3 | 1 |
| 2011 | 1 | 1 |
| 2012 | 1 | 0 |
| 2013 | 2 | 2 |
| 2014 | 7 | 0 |
| 2015 | 3 | 0 |
| 2016 | 3 | 2 |
| 2017 | 2 | 1 |
| 2018 | 1 | 1 |
| 2019 | 3 | 0 |
| 2020 | 4 | 3 |
| 2021 | 4 | 2 |
| 2022 | 6 | 1 |
| 2023 | 3 | 0 |
| 2024 | 6 | 1 |
| 2025 | 8 | 4 |
| 2026 | 4 | 0 |
Library tests named most
Largest condition groups
Phases
Participants
Lead sponsor: other 64. Interventional 54, observational 10.
As a primary outcomeSecondary or other outcomeVerbal Learning
The studies, newest registration first
Each number opens the study's record on ClinicalTrials.gov.
| Study | Start | Phase | Conditions | Participants | Lead sponsor | Status | Library tests named, with the latest time point |
|---|---|---|---|---|---|---|---|
| NCT07689500 | Start2025 | PhaseNot applicable | ConditionsDelirium, surgery and intensive care, Cardiovascular disease | Participants153 | Lead sponsorOther | StatusCompleted | Library tests named
|
| NCT07648498 | Start2026 | PhaseNot applicable | ConditionsCardiovascular disease | Participants30 | Lead sponsorOther | StatusRecruiting | Library tests named
|
| NCT07607795 | Start2026 | PhaseNot applicable | ConditionsCardiovascular disease | Participants30 | Lead sponsorOther | StatusRecruiting | Library tests named
|
| NCT07492537 | Start2025 | PhaseNot applicable | ConditionsDepression and bipolar disorder, Cardiovascular disease | Participants100 | Lead sponsorOther | StatusRecruiting | Library tests named
|
| NCT07396025 | Start2025 | PhaseNot applicable | ConditionsStroke, Cardiovascular disease | Participants60 | Lead sponsorOther | StatusRecruiting | Library tests named
|
| NCT07259434 | Start2026 | PhaseNot applicable | ConditionsCancer, Cardiovascular disease | Participants152 | Lead sponsorOther | StatusNot yet recruiting | Library tests named
|
| NCT07202000 | Start2026 | PhasePhase 2 | ConditionsCardiovascular disease | Participants48 | Lead sponsorOther | StatusRecruiting | Library tests named
|
| NCT06867198 | Start2025 | PhaseNot applicable | ConditionsObesity and diabetes, Cardiovascular disease | Participants72 | Lead sponsorOther | StatusRecruiting | Library tests named
|
| NCT06857994 | Start2025 | PhaseObservational | ConditionsObesity and diabetes, Cardiovascular disease | Participants101 | Lead sponsorOther | StatusCompleted | Library tests named
|
| NCT06855953 | Start2025 | PhaseNot applicable | ConditionsCardiovascular disease | Participants40 | Lead sponsorOther | StatusNot yet recruiting | Library tests named
|
| NCT06788275 | Start2024 | PhaseNot applicable | ConditionsCardiovascular disease | Participants132 | Lead sponsorOther | StatusRecruiting | Library tests named
|
| NCT06764121 | Start2025 | PhaseNot applicable | ConditionsCardiovascular disease | Participants32 | Lead sponsorOther | StatusActive, not recruiting | Library tests named
|
| NCT06735599 | Start2024 | PhaseNot applicable | ConditionsObesity and diabetes, Cardiovascular disease | Participants40 | Lead sponsorOther | StatusRecruiting | Library tests named
|
| NCT06697418 | Start2024 | PhaseObservational | ConditionsCardiovascular disease | Participants266 | Lead sponsorOther | StatusRecruiting | Library tests named
|
| NCT06554340 | Start2025 | PhaseNot applicable | ConditionsMultiple sclerosis, Cardiovascular disease | Participants80 | Lead sponsorOther | StatusRecruiting | Library tests named
|
| NCT06512922 | Start2024 | PhaseNot applicable | ConditionsAging, frailty and exercise, Cardiovascular disease | Participants120 | Lead sponsorOther | StatusRecruiting | Library tests named
|
| NCT06469515 | Start2024 | PhaseObservational | ConditionsDelirium, surgery and intensive care, Cardiovascular disease | Participants220 | Lead sponsorOther | StatusRecruiting | Library tests named
|
| NCT06336174 | Start2022 | PhaseObservational | ConditionsStroke, Cardiovascular disease | Participants100 | Lead sponsorOther | StatusRecruiting | Library tests named
|
| NCT05980195 | Start2024 | PhaseNot applicable | ConditionsCardiovascular disease | Participants90 | Lead sponsorOther | StatusStatus unknown | Library tests named
|
| NCT05848934 | Start2023 | PhaseObservational | ConditionsCardiovascular disease | Participants100 | Lead sponsorOther | StatusStatus unknown | Library tests named
|
| NCT05595577 | Start2023 | PhaseNot applicable | ConditionsCancer, Cardiovascular disease | Participants105 | Lead sponsorOther | StatusActive, not recruiting | Library tests named
|
| NCT05322824 | Start2022 | PhaseObservational | ConditionsCardiovascular disease | Participants500 | Lead sponsorOther | StatusRecruiting | Library tests named
|
| NCT05223426 | Start2023 | PhaseNot applicable | ConditionsCardiovascular disease | Participants54 | Lead sponsorOther | StatusStatus unknown | Library tests named
|
| NCT05200234 | Start2022 | PhaseNot applicable | ConditionsCardiovascular disease | Participants100 | Lead sponsorOther | StatusStatus unknown | Library tests named
|
| NCT05195788 | Start2022 | PhaseNot applicable | ConditionsCardiovascular disease | Participants100 | Lead sponsorOther | StatusStatus unknown | Library tests named
|
Questions, answered from the data
How many cardiovascular trials use Verbal Learning?
64 registered cardiovascular disease studies on ClinicalTrials.gov name it in an outcome measure, 21 of them in a primary outcome: 9% of the condition's 682 studies with a cognitive outcome, against 11% of all of them. It is the 3rd most named test in cardiovascular trials.
Which tests do cardiovascular trials use with Verbal Learning?
The Trail Making Test (31 studies), the Digit Span Test (29 studies) and Verbal Fluency (26 studies).
When do cardiovascular trials measure Verbal Learning?
Half of the primary outcomes that name Verbal Learning are measured within 6 months of the start, and the middle half from 13 weeks to 12 months. 20 primary outcomes give a duration.
How many completed cardiovascular trials that use Verbal Learning have reported results?
16 of the 27 completed studies that name it, 59%, have reported results: 12 posted them on ClinicalTrials.gov, 10 have a results paper linked to the registry record, and 6 did both. The other 11 show neither. Of all completed studies with a cognitive outcome, 46% have reported results.
How the studies are counted
For each test family, the census runs ClinicalTrials.gov's own outcome search for the family's names and reads every study first posted by the day the family was counted. These studies were read on 10 November 2026. A study counts once on a page, however many tests it names. Counts for a test cover every version of the task under any of its names, so a page can count studies that used a commercial version.
The census adds two things to each record and changes nothing in it: which outcome list names the test (primary, then secondary, then other), and the condition groups, matched on the study's condition names and MeSH terms. A study can fall in several groups; one whose only condition is cognitive impairment or decline falls in “Cognitive impairment and decline”. Studies that name only instruments outside the library count in every total and share but are not listed.
A second read on 10 November 2026 added each study's overall status, whether results are posted, its intervention types, the countries of its sites and the time frame of the outcome that names each test. A time frame counts by the latest time point it names: “Baseline, 12 and 24 weeks” is 24 weeks, a single visit is within a day, and one that names no duration, such as “end of treatment”, is left out of the timings.
A third read on 10 November 2026 added the papers the registry links to each study: those its sponsor lists as reporting results, and those PubMed links to it through the study's NCT number. A study has a results paper when one of them came out in or after the month of its primary completion and PubMed does not class it as a protocol, review or comment. A paper that never gives the NCT number is not linked, so some studies counted as reporting neither did publish.
Source: ClinicalTrials.gov, a database of the U.S. National Library of Medicine, which does not endorse these pages. Every study line is in the data release 2.1.0, and the explorer's own file is clinical-trials-studies.json.
The census counts Verbal Learning and Grocery Trip Game as one test family, so this page counts their studies together.
Run Verbal Learning in your trial
Choose tests with a record in registered trials, and run them in a browser at every site, on the same version each visit.